Dr. Jinhong Li

Dr. Jinhong LiJINHONG LI, M.D., Ph.D.
Anatomic Pathology, Clinical Pathology


100 North Academy Avenue
Danville, PA 17822-1920
1 800 695 6491

Dr. Li is an Associate of Geisinger Medical Laboratories at Geisinger Medical Center.

Education:

He received his M.D. from Binzhou Medical College, P. R. China. He also holds a Master's degree in Pathophysiology from Xi'an Medical University, P. R. China, and a Ph.D. in Physiology from Georgetown University, Washington, DC. He completed postdoctoral fellowship training at Harvard University and Massachusetts General Hospital, Boston, Mass.

Dr. Li received his pathology residency training at Brown University and Rhode Island Hospital and completed fellowships in surgical pathology with a subspecialty in genitourinary pathology at the University of Pennsylvania and in gastrointestinal and liver pathology at Emory University Hospital in Atlanta, Georgia.

Certifications:

Dr. Li is board certified in anatomic and clinical pathology. His areas of specialization include gastrointestinal and liver pathology, and urologic/genitourinary pathology.

Professional Affiliations:

United States and Canadian Academy of Pathology (USCAP)

Research Interests:

Gastrointestinal, liver pathology and genitourinary pathology.

Publications in Peer-Reviewed Journals:

Critchley-Thorne R., Prichard J, Diehl D, Li J, et al. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2016;25(6):956-968.

Critchley-Thorne RJ, Davison JM, Prichard JW, Reese LM, Zhang Y, Repa K, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi AH, Duits LC, Bergman JJ, Rustgi A, Falk GW. . A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev 2016;26(2):240-248.

Prichard JW, Davison JM, Campbell BB, Repa KA, Reese LM, Nguyen XM, Li J, Foxwell T, Taylor DL, Critchley-Thorne RJ. TissueCypherâ„¢: A systems biology approach to anatomic pathology. J Pathol Inform 2015;6:48.

Kim AH, Shellenberger MJ, Chen ZM, Li J. Case report of gastric outlet obstruction from metastatic lobular breast carcinoma. BMC Gastroenterol 2015;15:120.

Fairley KJ, Li J, Komar M, Steigerwalt N, Erlich P. Predicting the risk of recurrent adenoma and colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol. 2014;5:e64.

Abstracts, Posters, and Other Presentations:

Critchley-Thorne RJ, Davison JM, Prichard JW, Li J, Diehl DL, Reese L, Zhang Y, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Jobe BA, Zaidi A, Duits LC, Bergman J, Rustgi AK, Falk GW. A Tissue Systems Pathology Test Detects a Field Effect Associated with High Grade Dysplasia and Esophageal Cancer in Barrett’s Esophagus Patients. Poster Digestive Disease Week, San Diego, CA, May 21-24-2016.

Critchley-Thorne RJ, Duits LC, Prichard JW, Davison JM, Jobe BA, Campbell B, Zhang Y, Repa K, Reese L, Li J, Diehl DL, Jhala NC, Ginsberg GG, DeMarshall M, Foxwell T, Zaidi A, Taylor DL, Rustgi AK, Bergman J, Falk GW. A Novel Tissue Systems Pathology Test Predicts Progression in Barrett's Esophagus Patients. Lecture presentation Digestive Disease Week, San Diego, California, May 21-24, 2016.

Davison JM, Prichard JW, Campbell B, Repa K, Reese LM, Nguyen XM, Foxwell T, Li J, Diehl DL, Barley M, Falk GW, Jhala NC, DeMarshall M, Bergman J, Duits LC, Jobe BA, Zaidi A, Zhang Y, Critchley-Thorne RJ. Quantitative Multiplexed Biomarker and Morphology Analysis To Aid Diagnosis of Dysplasia in Barrett's Esophagus. Poster USCAP Annual Meeting, Boston, MA, March 21-27, 2015.

Chen Z, Yin H, Li J, Zhu S, Lin F. Improving HER2 assessment in gastroesophageal junction (GEJ) and gastric adenocarcinoma (GADC): lessons from concurrent immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) study of 117 specimens. Abstract/Presentation USCAP Annual Meeting, Boston, MA, March 2015.

Maio CL, Li JH, Mowery AD, Khara H, Inverso N, Yuasa K. A case of drug-induced liver injury by the new diabetes drug Canagliflozin. Presentation American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA, October 17-22, 2014.

Olson J, Pauli J, Erdman P, George M . Clinical outcomes of gravid patients with non-specific antibodies identified by solid phase testing during routine screening. Presentation American Association of Blood Banks, Tampa, Florida, October 25-28, 2014.

Pineda-Bonilla JJ, Johal Amitpal, Maio Chuan, Khara HS, Chen ZM, Li J, Prichard JW, Diehl DL. EUS-guided liver biopsy provides diagnostic samples with quantitative yields superior to percutaneous or transjugular routes. Presentation American Gastroenterological Association Digestive Disease Week, Chicago, IL, May 3-6, 2014.

Pineda-Bonilla, JJ, Kim, A, Johal A, Miao CL, Khara HS, Li JH, Prichard, JW, Chen ZM, Diehl DL . Assessment of hepatic steatosis by computerized image analysis using whole slide scanning technology. Presentation American Gastroenterological Association Digestive Disease Week, Chicago, IL, May 3-6, 2014.

Kip S, Prichard J, Chen E, Li J, Harrison H, Wehler A, Paynton B, Urban B, Knock B, Schicchitano, Rodino S. KRAS and BRAF Mutation Status in Correlation with MMR Protein Status in Colorectal Cancer Cases Diagnosed at Geisinger Health System. Poster 27 Geisinger Faculty Research Open House, Danville, PA, January 2014.

Textbook Chapters:

Li JH, Lin F. Upper gastrointestinal tract. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. New York: Springer; 2015: 535-542.

Chen ZM, LI J, Lin F. Lower gastrointestinal tract. In Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZM, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions, 2nd ed. New York: Springer; 2015: 543-556.

Locations  |    Search  |    Site Map |   Contact Us

©2000-2019 Geisinger Health System.   All rights reserved.